Literature DB >> 8941653

Estrogen suppresses activation but enhances formation phase of osteogenic response to mechanical stimulation in rat bone.

C J Jagger1, J W Chow, T J Chambers.   

Abstract

We used a model whereby mechanical stimulation induces bone formation in rat caudal vertebrae, to test the effect of estrogen on this osteogenic response. Unexpectedly, estrogen administered daily throughout the experiments (8-11 d) suppressed, and ovariectomy enhanced, mechanically induced osteogenesis. Osteogenesis was unaffected by the resorption-inhibitor pamidronate, suggesting that the suppression of bone formation caused by estrogen was not due to suppression of resorption. We found that estrogen did not significantly reduce the proportion of osteocytes that were induced by mechanical stimulation to express c-fos and IGF-I mRNA; and estrogen suppressed mechanically induced osteogenesis whether administration was started 24 h before or 24 h after loading. This suggests that estrogen acts primarily not on the strain-sensing mechanism itself, but on the osteogenic response to signals generated by strain-sensitive cells. We also found that when estrogen administration was started 3 d after mechanical stimulation, by which time osteogenesis is established, estrogen augmented the osteogenic response. This data is consistent with in vitro evidence for estrogen responsiveness in two phenotypically distinct bone cell types: stromal cells, whose functional activities are suppressed, and osteoblasts, which are stimulated, by estrogen.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8941653      PMCID: PMC507686          DOI: 10.1172/JCI119047

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  Osteoblastic insufficiency is responsible for maintenance of osteopenia after loss of ovarian function in experimental beagle dogs.

Authors:  H H Malluche; M C Faugere; M Rush; R Friedler
Journal:  Endocrinology       Date:  1986-12       Impact factor: 4.736

2.  The incidence of osteoporosis in normal women: its relation to age and the menopause.

Authors:  B E Nordin; J MacGregor; D A Smith
Journal:  Q J Med       Date:  1966-01

3.  Dynamic strain similarity in vertebrates; an alternative to allometric limb bone scaling.

Authors:  C T Rubin; L E Lanyon
Journal:  J Theor Biol       Date:  1984-03-21       Impact factor: 2.691

4.  Functional strain as a determinant for bone remodeling.

Authors:  L E Lanyon
Journal:  Calcif Tissue Int       Date:  1984       Impact factor: 4.333

Review 5.  The cellular basis of bone remodeling: the quantum concept reexamined in light of recent advances in the cell biology of bone.

Authors:  A M Parfitt
Journal:  Calcif Tissue Int       Date:  1984       Impact factor: 4.333

Review 6.  Coupling of bone formation to bone resorption: a broader view.

Authors:  Z F Jaworski
Journal:  Calcif Tissue Int       Date:  1984-09       Impact factor: 4.333

7.  Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment.

Authors:  R Lindsay; D M Hart; J M Aitken; E B MacDonald; J B Anderson; A C Clarke
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

8.  Osteocytic expression of mRNA for c-fos and IGF-I: an immediate early gene response to an osteogenic stimulus.

Authors:  J M Lean; A G Mackay; J W Chow; T J Chambers
Journal:  Am J Physiol       Date:  1996-06

9.  Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females.

Authors:  C Christiansen; M S Christensen; P McNair; C Hagen; K E Stocklund; I Transbøl
Journal:  Eur J Clin Invest       Date:  1980-08       Impact factor: 4.686

10.  Identification, characterization, and regulation of a rat complementary deoxyribonucleic acid which encodes insulin-like growth factor-I.

Authors:  L J Murphy; G I Bell; M L Duckworth; H G Friesen
Journal:  Endocrinology       Date:  1987-08       Impact factor: 4.736

View more
  21 in total

Review 1.  The role of FSH and TSH in bone loss and its clinical relevance.

Authors:  Manasi Agrawal; Guangyu Zhu; Li Sun; Mone Zaidi; Jameel Iqbal
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

2.  Additive effects of estrogen and mechanical stress on nitric oxide and prostaglandin E2 production by bone cells from osteoporotic donors.

Authors:  A D Bakker; J Klein-Nulend; E Tanck; G H Albers; P Lips; E H Burger
Journal:  Osteoporos Int       Date:  2004-11-16       Impact factor: 4.507

Review 3.  Osteocytes and Estrogen Deficiency.

Authors:  Laoise M McNamara
Journal:  Curr Osteoporos Rep       Date:  2021-11-26       Impact factor: 5.096

4.  New insights: elevated follicle-stimulating hormone and bone loss during the menopausal transition.

Authors:  Mone Zaidi; Harry C Blair; Jameel Iqbal; Terry F Davies; Ling Ling Zhu; Alberta Zallone; Li Sun
Journal:  Curr Rheumatol Rep       Date:  2009-07       Impact factor: 4.592

Review 5.  [Mechanobiology and bone metabolism: Clinical relevance for fracture treatment].

Authors:  M Haffner-Luntzer; A Liedert; A Ignatius
Journal:  Unfallchirurg       Date:  2015-12       Impact factor: 1.000

Review 6.  Sex steroid actions in male bone.

Authors:  Dirk Vanderschueren; Michaël R Laurent; Frank Claessens; Evelien Gielen; Marie K Lagerquist; Liesbeth Vandenput; Anna E Börjesson; Claes Ohlsson
Journal:  Endocr Rev       Date:  2014-09-09       Impact factor: 19.871

7.  Estrogen receptor-α is required for the osteogenic response to mechanical loading in a ligand-independent manner involving its activation function 1 but not 2.

Authors:  Sara H Windahl; Leanne Saxon; Anna E Börjesson; Marie K Lagerquist; Baruch Frenkel; Petra Henning; Ulf H Lerner; Gabriel L Galea; Lee B Meakin; Cecilia Engdahl; Klara Sjögren; Maria C Antal; Andrée Krust; Pierre Chambon; Lance E Lanyon; Joanna S Price; Claes Ohlsson
Journal:  J Bone Miner Res       Date:  2013-02       Impact factor: 6.741

8.  Mechano-transduction in osteoblastic cells involves strain-regulated estrogen receptor alpha-mediated control of insulin-like growth factor (IGF) I receptor sensitivity to Ambient IGF, leading to phosphatidylinositol 3-kinase/AKT-dependent Wnt/LRP5 receptor-independent activation of beta-catenin signaling.

Authors:  Andrew Sunters; Victoria J Armstrong; Gul Zaman; Robert M Kypta; Yoshiaki Kawano; Lance E Lanyon; Joanna S Price
Journal:  J Biol Chem       Date:  2009-12-30       Impact factor: 5.157

Review 9.  FSH and TSH in the regulation of bone mass: the pituitary/immune/bone axis.

Authors:  Graziana Colaianni; Concetta Cuscito; Silvia Colucci
Journal:  Clin Dev Immunol       Date:  2013-05-30

10.  Functional adaptation in female rats: the role of estrogen signaling.

Authors:  Susannah J Sample; Molly A Racette; Zhengling Hao; Cathy F Thomas; Mary Behan; Peter Muir
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.